马尔尼菲篮状菌感染对中国南方HIV/AIDS患者死亡率的影响:一项回顾性队列研究
该回顾性队列研究纳入中国广西南宁市第四人民医院2012—2015年住院的6791例HIV/AIDS患者,其中1093例(16.1%)合并马尔尼菲篮状菌感染。感染组死亡率为25.0/100人月(95%CI 21.5-26.7),显著高于未感染组的13.8/100人月(95%CI 12.5-15.1;调整后风险比1.80,95%CI 1.48-2.16),倾向性评分匹配后结果相似(调整后风险比4.52,95%CI 2.43-8.42)。
要点
- 住院HIV/AIDS患者中马尔尼菲篮状菌合并感染率为16.1%(1093/6791)。
- 合并感染组死亡率25.0/100人月,显著高于未感染组的13.8/100人月。
- 合并感染组死亡率在所有AIDS相关并发症中最高,各CD4+ T细胞计数分层下死亡风险均更高。
核心结论
- 马尔尼菲篮状菌感染在中国南方住院HIV/AIDS患者中常见,并与高于多数HIV相关并发症的死亡率相关。
- 作者认为这些结果凸显了改进该被忽视真菌病原体感染的诊断、治疗和预防的需要。
研究设计与样本
- 回顾性队列研究,纳入中国广西南宁市第四人民医院2012—2015年住院的HIV感染者。
- 共纳入6791例HIV/AIDS患者,其中1093例(16.1%)记录合并马尔尼菲篮状菌感染。
- 采用Kaplan-Meier法计算累积死亡率,Cox比例风险模型和1:1倾向性评分匹配评估感染对死亡率的影响。
主要发现
- 合并感染组死亡率为25.0/100人月(95%CI 21.5-26.7),未感染组为13.8/100人月(95%CI 12.5-15.1;调整后风险比1.80,95%CI 1.48-2.16)。
- 倾向性评分匹配后结果相似(调整后风险比4.52,95%CI 2.43-8.42)。
- 合并感染组死亡率在所有AIDS相关并发症中最高,也显著高于无任何并发症的患者。
- 按人口学特征分层,合并感染组在各层中死亡风险均更高;在任何CD4+ T细胞计数下合并感染均携带更高死亡风险。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Talaromyces marneffei is an opportunistic infection with high morbidity among human immunodeficiency virus (HIV)/AIDS patients in Southeast Asia and southern China. Its effects on mortality in HIV/AIDS patients has not been clearly elucidated. METHODS: We conducted a retrospective cohort study of hospitalized HIV-infected individuals at the Fourth People's Hospital of Nanning, Guangxi, China during 2012-2015. Kaplan-Meier analyses were used to calculate the cumulative mortality. Cox proportional hazard models and 1:1 propensity score matching (PSM) were used to evaluate the effects of T. marneffei infection on mortality of HIV/AIDS patients. RESULTS: In total, 6791 HIV/AIDS patients were included, 1093 of them (16.1%) with documented T. marneffei co-infection. The mortality of T. marneffei-infected patients (25.0 per 100 person-months, 95% CI 21.5-26.7) was the highest among all AIDS-associated complications and was significantly higher than that of T. marneffei-uninfected HIV/AIDS patients (13.8 per 100 person-months, 95% CI 12.5-15.1; adjusted hazard ratio (AHR) 1.80, 95% CI 1.48-2.16). The results using PSM were similar (AHR 4.52 95% CI 2.43-8.42). The mortality of T. marneffei-infected patients was also significantly higher than that of patients without any complications. When stratified by demographic characteristics, T. marneffei infection has higher mortality risk in all stratifications. Co-infection with T. marneffei carries a higher mortality risk in patients at any CD4+ T-cell count. CONCLUSIONS: Talaromyces marneffei infection is commonly found in hospitalized HIV/AIDS patients in southern China and was associated with a higher mortality rate than most HIV-associated complications. These results highlight the need for improved diagnosis, treatment and prevention of infection by this neglected fungal pathogen in southern China.
引用
- Jiang J, Meng S, Huang S, et al. Effects of Talaromyces marneffei infection on mortality of HIV/AIDS patients in southern China: a retrospective cohort study. Clin Microbiol Infect. 2018. PMID: 29698815. doi:10.1016/j.cmi.2018.04.018
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。